Cost of therapy for allergic rhinitis

South African Medical Journal

Volumn 87, Issue 2, 1997, Pages 141-145

  Wessels, Francois ^a   Green, Robin ^b   Luyt, David ^b  

^a Parklane Clinic ^*

^b Parklane Clinic   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHISTAMINIC AGENT; ASTEMIZOLE; CHOLINERGIC RECEPTOR BLOCKING AGENT; CORTICOSTEROID; CROMOGLYCATE DISODIUM; DECONGESTIVE AGENT; IPRATROPIUM BROMIDE; KETOTIFEN; KETOTIFEN FUMARATE; LEVOCABASTINE;

ALLERGIC RHINITIS; ARTICLE; COST EFFECTIVENESS ANALYSIS; DRUG CHOICE; DRUG COST; DRUG EFFICACY; HEALTH CARE COST; HUMAN; INTRANASAL DRUG ADMINISTRATION; ORAL DRUG ADMINISTRATION; SIDE EFFECT; TOPICAL DRUG ADMINISTRATION;

DOSAGE FORMS; DRUG COSTS; HISTAMINE H1 ANTAGONISTS; HUMANS; RHINITIS; SOUTH AFRICA;

EID: 0030912405     PISSN: 02569574     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Walters L, Smart AJ. Improving the cost-effective and rational utilisation of medicines in South Africa (Editorial). S Afr Med J 1994; 84: 820-821.
2. Moore WJ, Newman RJ. PharmacoEconomics I. ADIS, 1992.
3. Statement of the working group of the South African Pulmonology Society. Guidelines for the management of asthma in adults in South Africa. Part I. Chronic persistent asthma. S Afr Med J 1992; 81: 319-322.
4. South African Childhood Asthma Working Group. Management of acute asthmatic attacks in children. S Afr Med J 1993; 83: 286-289.
5. Statement of the working group of the South African Pulmonology Society. Guidelines for the management of asthma in adults in South Africa. Part II. Acute asthma. S Afr Med J 1994; 84: 332-338.
6. South African Childhood Asthma Working Group. Management of childhood and adolescent asthma - 1994 Consensus. S Afr Med J 1 994; 84: 862-866.
7. Broshy E, Matheson D, Hansen M. Want to curb health costs? Manage the disease, not each cost component. Medical Marketing and Media 1993; Sept: 76-84.
8. Sibbald B, Rink E. Epidemiology of seasonal and perennial rhinitis: clinical presentation and medical history. Thorax 1991; 46: 395-901.
9. Aberg N. Asthma and allergic rhinitis in Swedish conscripts. Clin Exp Allergy 1989; 19: 59-53.
10. Juniper EF, Guyatt GH. Development and testing of a new measure of health status for clinical trials in rhinoconjunctivitis. Clin Exp Allergy 1991; 21: 77-83.
11. Juniper EF, Guyatt GH, Andersson B, Ferrie PJ. Comparison of powder and aerosolized budesonide in perennial rhinitis: validation of rhinitis quality of life questionnaire. Ann Allergy 1993; 70: 225-230.
12. Potter PC, Berman D, Toerien A, Malherbe D, Weinberg EG. Clinical significance of aero-allergen identification in the Western Cape. S Afr Med J 1991; 79: 80-84.
13. Davis G, Luyt D, Prescott R, Potter PC. House-dust mites in Soweto. Current Allergy and Clinical Immunology 1994; 7(1): 16-17.
14. MIMS Medical Specialities 1935; 35(4).
15. International Rhinitis Management Working Group. International consensus report on the diagnoses and management of rhinitis. Allergy 1994; 49(19): 1-34.
16. UCB Quiz on Quality-of-Life issue, ICACI/EAACI Congress, Stockholm 1994. UCB Pharma. Brussels: UCB, 1994.
17. 1-receptor antagonists. Clin Exp Allergy 1994; 24: 707-723.
18. Boner AL, Sette L. Rhinitis in children: efficacy and safety of a new intranasal corticosteroid. Eur Respir Rev 1994; 20: 271-273.